Stock Market & Financial Investment News

News Breaks January 2, 2013 08:45 EDT AMAG, SNY AMAG Pharmaceuticals names Greg Madison as Chief Commercial Officer He joins AMAG from Genzyme Corporation (SNY), where he spent the past 12 years in various commercial roles in their renal division, most recently as the division’s vice president and general manager. News For AMAG;SNY From The Last 14 Days Check below for free stories on AMAG;SNY the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 23, 2013 08:18 EDT SNY Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi Subscribe for More Information May 22, 2013 08:59 EDT AMAG On The Fly: Pre-market Movers Subscribe for More Information May 21, 2013 18:56 EDT AMAG On The Fly: After Hours Movers Subscribe for More Information 17:34 EDT AMAG AMAG says Takeda recalling one batch of Rienso from Swiss market Subscribe for More Information 08:47 EDT AMAG AMAG Pharmaceuticals Ferumoxytol treatment significant hemoglobin increases AMAG Pharmaceuticals announced that a new sub-group analysis from IDA-301, a phase III, randomized, placebo-controlled clinical trial, will be presented today at the Digestive Disease Week 2013 meeting in Orlando, Florida. In the full IDA-301 study, 608 adult patients with iron deficiency anemia who had failed or could not tolerate oral iron were treated with ferumoxytol and 200 received placebo. The data from this study showed a direct correlation between a rise in hemoglobin levels and improvements in patients' self-reported measures of fatigue. GI patients with iron deficiency anemia who have not responded well to oral iron supplementation have a need for additional treatment options. The analysis from this study supports the potential of ferumoxytol as a new treatment option for patients with IDA from GI disease who have previously had an unsatisfactory response to oral iron therapy 07:44 EDT SNY Sachs Associates to host a forum Subscribe for More Information May 20, 2013 17:26 EDT SNY Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement' Subscribe for More Information 11:27 EDT SNY Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva Subscribe for More Information May 17, 2013 08:03 EDT SNY Sanofi reports positive topline results from pivotal Phase III Jakarta study Subscribe for More Information 05:18 EDT SNY Sanofi says JAK2 inhibitor for myelofibrosis met primary endpoint Subscribe for More Information May 15, 2013 15:16 EDT SNY Sanofi systemic sclerosis treatment designated for orphan drug status Subscribe for More Information 09:53 EDT AMAG AMAG Pharmaceuticals management to meet with Leerink Subscribe for More Information 05:39 EDT SNY Sanofi, Regeneron announce patient enrollment in two Phase 3 trials Subscribe for More Information May 13, 2013 09:44 EDT SNY Several companies reportedly interested in buying Adcock Ingram, Globes says Subscribe for More Information 07:30 EDT SNY TechConnect to host a summit 2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. May 10, 2013 11:48 EDT SNY Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.